Polo, Miya .

HRN: 21-12-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2026
CEFUROXIME 1.5GM (VIAL)
01/11/2026
01/14/2026
IVT
1.5g
Q8
S/p CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines